Reckitt Benckiser Group plc (OTCMKTS:RBGPF – Get Free Report) traded down 1.8% on Thursday . The company traded as low as $58.90 and last traded at $59.59. 247 shares changed hands during mid-day trading, a decline of 90% from the average session volume of 2,409 shares. The stock had previously closed at $60.67.
Reckitt Benckiser Group Stock Performance
The company’s 50-day moving average price is $60.34 and its two-hundred day moving average price is $58.94.
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Featured Articles
- Five stocks we like better than Reckitt Benckiser Group
- Buy P&G Now, Before It Sets A New All-Time High
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- Financial Services Stocks Investing
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- ETF Screener: Uses and Step-by-Step Guide
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
